Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects
Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different ex...
Gespeichert in:
| Veröffentlicht in: | European journal of endocrinology Jg. 171; H. 3; S. 343 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
01.09.2014
|
| Schlagworte: | |
| ISSN: | 1479-683X, 1479-683X |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different exercise workloads and intensities on circulating irisin levels immediately post-exercise.
In a pilot study, four healthy subjects (22.5±1.7 years) underwent maximal workload exercise (maximal oxygen consumption, VO2 max) and blood was drawn at prespecified intervals to define the time frame of pre- and post-exercise irisin changes over a 24-h period. In the main study, 35 healthy, non-smoking (23.0±3.3 years) men and women (n=20/15) underwent three exercise protocols ≥48-h apart, in random order: i) maximal workload (VO2 max); ii) relative workload (70% of VO2 max/10 min); and iii) absolute workload (75 W/10 min). Blood was drawn immediately pre-exercise and 3 min post-exercise.
In the pilot study, irisin levels increased by 35% 3 min post-exercise, then dropped and remained relatively constant. In the main study, irisin levels post-exercise were significantly higher than those of pre-exercise after all workloads (all, P<0.001). Post-to-pre-exercise differences in irisin levels were significantly different between workloads (P=0.001), with the greatest increase by 34% following maximal workload (P=0.004 vs relative and absolute).
Circulating irisin levels were acutely elevated in response to exercise, with a greater increase after maximal workload. These findings suggest that irisin release could be a function of muscle energy demand. Future studies need to determine the underlying mechanisms of irisin release and explore irisin's therapeutic potential. |
|---|---|
| AbstractList | Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different exercise workloads and intensities on circulating irisin levels immediately post-exercise.
In a pilot study, four healthy subjects (22.5±1.7 years) underwent maximal workload exercise (maximal oxygen consumption, VO2 max) and blood was drawn at prespecified intervals to define the time frame of pre- and post-exercise irisin changes over a 24-h period. In the main study, 35 healthy, non-smoking (23.0±3.3 years) men and women (n=20/15) underwent three exercise protocols ≥48-h apart, in random order: i) maximal workload (VO2 max); ii) relative workload (70% of VO2 max/10 min); and iii) absolute workload (75 W/10 min). Blood was drawn immediately pre-exercise and 3 min post-exercise.
In the pilot study, irisin levels increased by 35% 3 min post-exercise, then dropped and remained relatively constant. In the main study, irisin levels post-exercise were significantly higher than those of pre-exercise after all workloads (all, P<0.001). Post-to-pre-exercise differences in irisin levels were significantly different between workloads (P=0.001), with the greatest increase by 34% following maximal workload (P=0.004 vs relative and absolute).
Circulating irisin levels were acutely elevated in response to exercise, with a greater increase after maximal workload. These findings suggest that irisin release could be a function of muscle energy demand. Future studies need to determine the underlying mechanisms of irisin release and explore irisin's therapeutic potential. Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different exercise workloads and intensities on circulating irisin levels immediately post-exercise.BACKGROUNDIrisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the beneficial effects of exercise. We aimed to estimate the time frame of changes in irisin levels after acute exercise and the effect of different exercise workloads and intensities on circulating irisin levels immediately post-exercise.In a pilot study, four healthy subjects (22.5±1.7 years) underwent maximal workload exercise (maximal oxygen consumption, VO2 max) and blood was drawn at prespecified intervals to define the time frame of pre- and post-exercise irisin changes over a 24-h period. In the main study, 35 healthy, non-smoking (23.0±3.3 years) men and women (n=20/15) underwent three exercise protocols ≥48-h apart, in random order: i) maximal workload (VO2 max); ii) relative workload (70% of VO2 max/10 min); and iii) absolute workload (75 W/10 min). Blood was drawn immediately pre-exercise and 3 min post-exercise.METHODSIn a pilot study, four healthy subjects (22.5±1.7 years) underwent maximal workload exercise (maximal oxygen consumption, VO2 max) and blood was drawn at prespecified intervals to define the time frame of pre- and post-exercise irisin changes over a 24-h period. In the main study, 35 healthy, non-smoking (23.0±3.3 years) men and women (n=20/15) underwent three exercise protocols ≥48-h apart, in random order: i) maximal workload (VO2 max); ii) relative workload (70% of VO2 max/10 min); and iii) absolute workload (75 W/10 min). Blood was drawn immediately pre-exercise and 3 min post-exercise.In the pilot study, irisin levels increased by 35% 3 min post-exercise, then dropped and remained relatively constant. In the main study, irisin levels post-exercise were significantly higher than those of pre-exercise after all workloads (all, P<0.001). Post-to-pre-exercise differences in irisin levels were significantly different between workloads (P=0.001), with the greatest increase by 34% following maximal workload (P=0.004 vs relative and absolute).RESULTSIn the pilot study, irisin levels increased by 35% 3 min post-exercise, then dropped and remained relatively constant. In the main study, irisin levels post-exercise were significantly higher than those of pre-exercise after all workloads (all, P<0.001). Post-to-pre-exercise differences in irisin levels were significantly different between workloads (P=0.001), with the greatest increase by 34% following maximal workload (P=0.004 vs relative and absolute).Circulating irisin levels were acutely elevated in response to exercise, with a greater increase after maximal workload. These findings suggest that irisin release could be a function of muscle energy demand. Future studies need to determine the underlying mechanisms of irisin release and explore irisin's therapeutic potential.CONCLUSIONSCirculating irisin levels were acutely elevated in response to exercise, with a greater increase after maximal workload. These findings suggest that irisin release could be a function of muscle energy demand. Future studies need to determine the underlying mechanisms of irisin release and explore irisin's therapeutic potential. |
| Author | Daskalopoulou, Stella S Mutter, Andrew F Mesfum, Ertirea T Gomez, Yessica-Haydee Cooke, Alexandra B Filippaios, Andreas Mantzoros, Christos S |
| Author_xml | – sequence: 1 givenname: Stella S surname: Daskalopoulou fullname: Daskalopoulou, Stella S email: stella.daskalopoulou@mcgill.ca organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USADivision of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA stella.daskalopoulou@mcgill.ca – sequence: 2 givenname: Alexandra B surname: Cooke fullname: Cooke, Alexandra B organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA – sequence: 3 givenname: Yessica-Haydee surname: Gomez fullname: Gomez, Yessica-Haydee organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA – sequence: 4 givenname: Andrew F surname: Mutter fullname: Mutter, Andrew F organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA – sequence: 5 givenname: Andreas surname: Filippaios fullname: Filippaios, Andreas organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA – sequence: 6 givenname: Ertirea T surname: Mesfum fullname: Mesfum, Ertirea T organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA – sequence: 7 givenname: Christos S surname: Mantzoros fullname: Mantzoros, Christos S organization: Division of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USADivision of Experimental MedicineDepartment of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaDivision of Internal MedicineDepartment of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec, CanadaEndocrinology SectionVA Boston Healthcare System, Boston, Massachusetts, USADivision of EndocrinologyDiabetes and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24920292$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkEtPwzAQhC1URB9w4o585NCA7bhOckRVeakSHEDiFtnOpnVx7RInQMSfxwgqcdpvR7MjzY7RwHkHCJ1SckFnKblc3C8SyhPCCD9AI8qzIhF5-jL4x0M0DmFDCBU8JUdoyHjBCCvYCH09Whm2EpvGBOOwhXewAe8av2ogBBO3HhunG5ABIuCo7ryL3Pq9btwKwyc02kT5wzev1ssq_Jh737nVFK9B2nbdT7HUbUzEoVMb0G04Roe1tAFO_uYEPV8vnua3yfLh5m5-tUwUF7xN0oxmNSEpKKHTnKhCqTrXdUYFEUyzWuSi4FpRShjlRICkVbwreFXwus5Bswk6_82Ntd46CG25NUGDtdKB70JJZzynxYxkLFrP_qyd2kJV7hqzlU1f7h_GvgFcJXBz |
| CitedBy_id | crossref_primary_10_1007_s11332_022_00924_1 crossref_primary_10_1186_s12944_019_0960_4 crossref_primary_10_1242_jeb_198424 crossref_primary_10_1161_CIRCRESAHA_124_325614 crossref_primary_10_3390_ijerph20196872 crossref_primary_10_5812_asjsm_13025 crossref_primary_10_1007_s12272_017_0994_y crossref_primary_10_3389_fphys_2018_01307 crossref_primary_10_1016_j_exger_2015_07_006 crossref_primary_10_1515_cclm_2017_0674 crossref_primary_10_1371_journal_pone_0170690 crossref_primary_10_1016_j_cmet_2015_08_001 crossref_primary_10_1016_j_exger_2025_112850 crossref_primary_10_3390_sports11110215 crossref_primary_10_3390_sports11040090 crossref_primary_10_1016_j_jesf_2023_11_002 crossref_primary_10_1016_j_scispo_2021_10_003 crossref_primary_10_1096_fj_201700983RR crossref_primary_10_4103_NRR_NRR_D_24_00098 crossref_primary_10_1007_s42000_020_00214_w crossref_primary_10_1016_j_metabol_2015_05_010 crossref_primary_10_3920_CEP200050 crossref_primary_10_14814_phy2_70411 crossref_primary_10_1111_sms_12904 crossref_primary_10_3233_BPL_150019 crossref_primary_10_1038_srep18732 crossref_primary_10_1053_j_jrn_2020_05_005 crossref_primary_10_1016_j_obmed_2015_12_002 crossref_primary_10_1002_edm2_370 crossref_primary_10_1111_cen_12672 crossref_primary_10_32604_biocell_2024_048776 crossref_primary_10_3920_CEP210015 crossref_primary_10_1016_j_crphys_2025_100163 crossref_primary_10_1016_j_ypmed_2017_04_027 crossref_primary_10_1177_10998004221142580 crossref_primary_10_20473_fmi_v56i1_24603 crossref_primary_10_3390_biology11030392 crossref_primary_10_1038_srep08889 crossref_primary_10_1038_ijo_2017_255 crossref_primary_10_1093_function_zqaf017 crossref_primary_10_23736_S0022_4707_20_11076_4 crossref_primary_10_1515_hmbci_2020_0007 crossref_primary_10_1139_apnm_2024_0091 crossref_primary_10_3390_cells11010160 crossref_primary_10_12677_OJNS_2021_91018 crossref_primary_10_1111_ejn_15493 crossref_primary_10_1249_MSS_0000000000003136 crossref_primary_10_1111_apha_13766 crossref_primary_10_1371_journal_pone_0189254 crossref_primary_10_1016_j_heliyon_2022_e12352 crossref_primary_10_1016_j_scispo_2020_04_006 crossref_primary_10_1002_oby_21029 crossref_primary_10_1016_j_jtherbio_2022_103189 crossref_primary_10_1016_j_jtherbio_2022_103344 crossref_primary_10_29407_js_unpgri_vi_14289 crossref_primary_10_1016_j_scispo_2023_04_009 crossref_primary_10_1016_j_metabol_2015_12_006 crossref_primary_10_3390_ijerph18116042 crossref_primary_10_1080_1612197X_2023_2255604 crossref_primary_10_3390_sports8120157 crossref_primary_10_1016_j_psyneuen_2021_105597 crossref_primary_10_3390_ijerph17113863 crossref_primary_10_1080_02640414_2020_1739896 crossref_primary_10_1016_j_metabol_2015_01_001 crossref_primary_10_3390_jcm12010369 crossref_primary_10_1210_endocr_bqaa076 crossref_primary_10_1016_j_peptides_2025_171439 crossref_primary_10_1373_jalm_2017_025296 crossref_primary_10_31362_patd_1102543 crossref_primary_10_3389_fphys_2020_562895 crossref_primary_10_1038_s41430_017_0058_x crossref_primary_10_29407_js_unpgri_v7i2_15932 crossref_primary_10_1016_j_jesf_2020_06_004 crossref_primary_10_1007_s40519_018_0491_4 crossref_primary_10_3390_cells9061478 crossref_primary_10_3390_ijms19113447 crossref_primary_10_1007_s12020_016_0913_x crossref_primary_10_3390_jcdd9090305 crossref_primary_10_3389_fphys_2021_689696 crossref_primary_10_1139_apnm_2019_0624 crossref_primary_10_3390_ijms18061260 crossref_primary_10_1016_j_arr_2015_02_004 crossref_primary_10_3389_fphys_2024_1410068 crossref_primary_10_1016_j_ghir_2015_12_008 crossref_primary_10_1007_s12662_024_00984_0 crossref_primary_10_1016_j_scispo_2016_07_005 crossref_primary_10_1113_EP092319 crossref_primary_10_1007_s13105_015_0433_9 crossref_primary_10_3390_medicina56060274 crossref_primary_10_1016_j_metabol_2014_10_024 crossref_primary_10_1016_j_neuroscience_2020_03_042 crossref_primary_10_1055_a_1297_4669 crossref_primary_10_1530_EJE_17_0572 crossref_primary_10_3390_ijerph17103589 crossref_primary_10_3389_fendo_2021_724911 crossref_primary_10_1016_j_exger_2022_111744 crossref_primary_10_1186_s12885_023_11391_3 crossref_primary_10_1007_s12020_015_0834_0 crossref_primary_10_1007_s40519_017_0431_8 crossref_primary_10_1016_j_bbr_2021_113472 crossref_primary_10_1016_j_lfs_2020_118954 crossref_primary_10_1007_s12576_018_0619_3 crossref_primary_10_1016_j_ijcard_2025_133861 crossref_primary_10_1155_2017_1039161 crossref_primary_10_1007_s11892_020_01319_7 crossref_primary_10_1016_j_yfrne_2022_100993 crossref_primary_10_1016_j_jshs_2024_04_005 crossref_primary_10_1186_s12967_024_04956_8 crossref_primary_10_1097_GME_0000000000001388 crossref_primary_10_1016_j_bbalip_2018_04_013 crossref_primary_10_1016_j_metabol_2015_02_009 crossref_primary_10_3390_ijms26010350 crossref_primary_10_29407_js_unpgri_v8i2_17674 crossref_primary_10_3390_life11111227 crossref_primary_10_1016_j_exger_2025_112821 crossref_primary_10_3920_CEP210038 crossref_primary_10_1007_s11010_025_05225_y crossref_primary_10_14814_phy2_13539 |
| ContentType | Journal Article |
| Copyright | 2014 European Society of Endocrinology. |
| Copyright_xml | – notice: 2014 European Society of Endocrinology. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1530/EJE-14-0204 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1479-683X |
| ExternalDocumentID | 24920292 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Canadian Institutes of Health Research grantid: 102626 |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 5WD AABZA AACZT AAPGJ AAPXW AARHZ AAUAY AAVAP AAWDT ABDFA ABEJV ABGNP ABIME ABJNI ABMNT ABNHQ ABOCM ABPIB ABPQP ABPTD ABQNK ABSQV ABVGC ABWST ABXVV ABXZS ACFRR ACGFO ACNCT ACPRK ACUTJ ADBBV ADGKP ADIPN ADMTO ADNBA ADQBN ADVEK ADVOB AEMQT AENEX AFFNX AFGWE AFHIN AFXAL AFYAG AGORE AGQXC AGUTN AHGBF AHMMS AI. AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALXQX ANFBD APJGH ATGXG BAWUL BCRHZ BTFSW C1A CGR CS3 CUY CVF DU5 E3Z EBS ECM EIF EJD EMOBN F9R GX1 H13 HZ~ IL9 INIJC J5H KOP KQ8 L7B NPM NU- O9- OAUYM OBFPC OBOKY OCZFY OJZSN OK1 OPAEJ OVD OWPYF P2P ROX SJN TBS TCN TEORI TMA TR2 VH1 W8F WOQ X7M ZGI ZXP 7X8 |
| ID | FETCH-LOGICAL-b464t-3717f003eb6c380b9bbf8cf716062c2f68694cb11021406ea1d46494d94ff8ec2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 157 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000343670900012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1479-683X |
| IngestDate | Wed Oct 01 14:36:13 EDT 2025 Mon Jul 21 05:56:55 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | 2014 European Society of Endocrinology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b464t-3717f003eb6c380b9bbf8cf716062c2f68694cb11021406ea1d46494d94ff8ec2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://eje.bioscientifica.com/downloadpdf/journals/eje/171/3/343.pdf |
| PMID | 24920292 |
| PQID | 1548195072 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1548195072 pubmed_primary_24920292 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-09-01 |
| PublicationDateYYYYMMDD | 2014-09-01 |
| PublicationDate_xml | – month: 09 year: 2014 text: 2014-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | European journal of endocrinology |
| PublicationTitleAlternate | Eur J Endocrinol |
| PublicationYear | 2014 |
| SSID | ssj0016430 |
| Score | 2.518387 |
| Snippet | Irisin, a recently discovered myokine, has been shown to induce browning of white adipose tissue, enhancing energy expenditure and mediating some of the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 343 |
| SubjectTerms | Adolescent Adult Biomarkers - blood Energy Metabolism - physiology Exercise - physiology Female Fibronectins - blood Health Status Humans Male Oxygen Consumption - physiology Pilot Projects Young Adult |
| Title | Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24920292 https://www.proquest.com/docview/1548195072 |
| Volume | 171 |
| WOSCitedRecordID | wos000343670900012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwEA_qRHzxY_NjfhFBfFqwTbM0eRKRDRE39qCwt9GkCQy2dq6bMPznvaQdexIEX0pbmlLSy93v7n6XQ-hOCN1mMdOESXBXmRSMgJWzxIRpQjXXhhtfKPwW9_tiOJSDKuBWVLTKtU70ijrNtYuRPzho7VqWxvRx9klc1yiXXa1aaGyjWgRQxi3MeLjJIoC19QWRLJaEi2hY1ee1o-Ch89ohISOuNPR3bOltTPfwv193hA4qdImfSnE4Rlsmq6PGUwae9XSF77Hne_pAeh3t9aq0egN9DwBDTxM8hhU_zvDEEYkK7KlbjiULVys8zhy-LAyc4HlJrDV4ka_vgwXE6_ZN2JG9JnmSFu7hldMnLVwWXK5aOPEaFhdL5UJAxQn66Hben19I1ZWBKMbZAjRSGFvQBUZxHYlASaWs0Bb8roBTTS0XXDKtQt8zPOAmCVMYJ1kqmbXCaHqKdrI8M-cIK01FChhD6ZgybcB5s0ZaGNJW8K4kaqLb9WyPQOpdKiPJTL4sRpv5bqKz8peNZuX2HCO3B2JAJb34w-hLtA8IiJWksStUs7DmzTXa1V-LcTG_8eIEx_6g9wNWz9dG |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+irisin+levels+progressively+increase+in+response+to+increasing+exercise+workloads+in+young%2C+healthy%2C+active+subjects&rft.jtitle=European+journal+of+endocrinology&rft.au=Daskalopoulou%2C+Stella+S&rft.au=Cooke%2C+Alexandra+B&rft.au=Gomez%2C+Yessica-Haydee&rft.au=Mutter%2C+Andrew+F&rft.date=2014-09-01&rft.eissn=1479-683X&rft.volume=171&rft.issue=3&rft.spage=343&rft_id=info:doi/10.1530%2FEJE-14-0204&rft_id=info%3Apmid%2F24920292&rft_id=info%3Apmid%2F24920292&rft.externalDocID=24920292 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-683X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-683X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-683X&client=summon |